EGFR and cancer: An active interaction between COX2, encoded by PTGS2 and the EGFR pathway is well-established in carcinogenesis [106,107], and similar to EGFR, COX2 activity is related to impaired immune surveillance and cancer immune evasion by triggering immunosuppressive properties of diverse cells in the TIME [108,109,110].